The SAP is a Health Canada program that allows individuals to receive psilocybin and MDMA assisted therapy when they have exhausted their search for relief for end-of-life distress, Major Depressive Disorders (MDD) and Post-Traumatic Stress Disorder (PTSD) without success.
Thursday October 26, 2023 @ 6:00 pm – 7:00 pm MST MAPS recently published the results of their Phase 3B MDMA […]
Thursday November 16, 2023 @ 6:00 pm – 7:00 pm MST Ketamine possesses the potential to disrupt detrimental behavioral patterns, particularly those intertwined […]
Thursday December 7, 2023 @ 6:00 pm – 7:00 pm MDT Join our network and begin offering psychedelic-assisted therapy to much needed […]
Register Here Embarking on the journey to become an effective compassionate witness in the psychedelic realm is akin to transforming into […]
Register Here Join Dr. Scott Shannon (MAPS principal investigator on its Phase 3 MDMA Clinical Trial), and ATMA CEO, Vu Tran to learn more about […]
Register Here Join us for an exclusive fireside chat with the visionary team behind the Psychedelic Puppet Show while we come […]
Register Here Join us on as epic visual trip as we talk to author, professor, and Canadian historian, Dr Erika Dyck about her […]
ATMA’s Phase II Psilocybin-assisted Therapy Clinical Trial has now received a No Objection Letter from Health Canada, as well as approval from […]
BACK TO TOP
